BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30866687)

  • 41. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 Registry.
    Luçon A; Oger E; Bedossa M; Boulmier D; Verhoye JP; Eltchaninoff H; Iung B; Leguerrier A; Laskar M; Leprince P; Gilard M; Le Breton H
    Circ Cardiovasc Interv; 2014 Apr; 7(2):240-7. PubMed ID: 24569597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
    Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
    Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic impact of pulmonary artery systolic pressure in patients undergoing transcatheter aortic valve replacement for aortic stenosis.
    Bishu K; Suri RM; Nkomo VT; Kane GC; Greason KL; Reeder GS; Mathew V; Holmes DR; Rihal CS; Melduni RM
    Am J Cardiol; 2014 Nov; 114(10):1562-7. PubMed ID: 25260946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Sinning JM; Wollert KC; Sedaghat A; Widera C; Radermacher MC; Descoups C; Hammerstingl C; Weber M; Stundl A; Ghanem A; Widder J; Vasa-Nicotera M; Mellert F; Schiller W; Bauersachs J; Zur B; Holdenrieder S; Welz A; Grube E; Pencina MJ; Nickenig G; Werner N; Kempf T
    Am Heart J; 2015 Oct; 170(4):821-9. PubMed ID: 26386807
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry.
    Van Belle E; Juthier F; Susen S; Vincentelli A; Iung B; Dallongeville J; Eltchaninoff H; Laskar M; Leprince P; Lievre M; Banfi C; Auffray JL; Delhaye C; Donzeau-Gouge P; Chevreul K; Fajadet J; Leguerrier A; Prat A; Gilard M; Teiger E;
    Circulation; 2014 Apr; 129(13):1415-27. PubMed ID: 24566199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of Long-Term Structural Deterioration of Transcatheter Aortic Bioprosthetic Valves Using the New European Definition.
    Durand E; Sokoloff A; Urena-Alcazar M; Chevalier B; Chassaing S; Didier R; Tron C; Litzler PY; Bouleti C; Himbert D; Hovasse T; Bar O; Avinée G; Iung B; Blanchard D; Gilard M; Cribier A; Lefevre T; Eltchaninoff H
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007597. PubMed ID: 30998397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intraprocedural invasive hemodynamic parameters as predictors of short- and long-term outcomes in patients undergoing transcatheter aortic valve replacement.
    Kiramijyan S; Koifman E; Magalhaes MA; Ben-Dor I; Didier R; Jerusalem ZD; Kumar S; Tavil-Shatelyan A; Rogers T; Steinvil A; Gai J; Torguson R; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2018 Apr; 19(3 Pt A):257-262. PubMed ID: 29174824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Serum C-Reactive Protein Level on Admission to Predict Mortality After Transcatheter Aortic Valve Implantation.
    Hioki H; Watanabe Y; Kozuma K; Yamamoto M; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Higashimori A; Mizutani K; Tabata M; Takagi K; Ueno H; Hayashida K;
    Am J Cardiol; 2018 Jul; 122(2):294-301. PubMed ID: 29735216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GDF-15 (Growth Differentiation Factor 15) Is Associated With Lack of Ventricular Recovery and Mortality After Transcatheter Aortic Valve Replacement.
    Kim JB; Kobayashi Y; Moneghetti KJ; Brenner DA; O'Malley R; Schnittger I; Wu JC; Murtagh G; Beshiri A; Fischbein M; Miller DC; Liang D; Yeung AC; Haddad F; Fearon WF
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29222133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
    Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
    Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
    Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
    Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
    Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
    JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Wait Time for Transcatheter Aortic Valve Replacement and Early Postprocedural Outcomes.
    Elbaz-Greener G; Yarranton B; Qiu F; Wood DA; Webb JG; Fremes SE; Radhakrishnan S; Wijeysundera HC
    J Am Heart Assoc; 2019 Jan; 8(1):e010407. PubMed ID: 30612506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis.
    Besch G; Pili-Floury S; Morel C; Gilard M; Flicoteaux G; Salomon du Mont L; Perrotti A; Meneveau N; Chocron S; Schiele F; Le Breton H; Samain E; Chopard R
    Cardiovasc Diabetol; 2019 Mar; 18(1):27. PubMed ID: 30857532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relation of Clinical Presentation of Aortic Stenosis and Survival Following Transcatheter Aortic Valve Implantation.
    Ben-Shoshan J; Zahler D; Margolis G; Arbel Y; Konigstein M; Chorin E; Steinvil A; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2019 Mar; 123(6):961-966. PubMed ID: 30595395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and effect of myocardial injury after transcatheter aortic valve replacement.
    Barbash IM; Dvir D; Ben-Dor I; Badr S; Okubagzi P; Torguson R; Corso PJ; Xue Z; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 May; 111(9):1337-43. PubMed ID: 23415511
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
    Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.